AgeX goes public on NYSE and share price immediately doubles. Congrats Aubrey de Grey, Michael West AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc, applying technology relating to cellular immortality and regenerative biology. “A growing sum of company and investment capital is making its way into the study of aging with the aim not only …
Life Extension through Genomics & Bio-Hacking